It is worth noting that patients with DDR pathway activation in the mUC cohort showed significantly higher NAL levels than those without DDR activation (p=0.00027) (Figure 3A), and similar results were found in the TCGA-BLCA cohort (p=0.0025) (Figure 3B). The gene discussed is NPL; the disease is bladder transitional cell carcinoma.